Equities

Fagron NV

Fagron NV

Actions
Health CareMedical Equipment and Services
  • Price (USD)20.03
  • Today's Change0.00 / 0.00%
  • Shares traded1.10k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 06 2024 17:18 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments13712571
Total Receivables, Net858472
Total Inventory11410891
Prepaid expenses------
Other current assets, total0.00--0.00
Total current assets336318234
Property, plant & equipment, net148144129
Goodwill, net434430380
Intangibles, net493431
Long term investments6.71172.75
Note receivable - long term----1.71
Other long term assets4.583.730.00
Total assets1,007971800
LIABILITIES
Accounts payable1059884
Accrued expenses454028
Notes payable/short-term debt000
Current portion long-term debt/capital leases9.681914
Other current liabilities, total151419
Total current liabilities175171145
Total long term debt357380321
Total debt367399336
Deferred income tax1.984.352.51
Minority interest3.875.985.36
Other liabilities, total5.034.766.11
Total liabilities543566480
SHAREHOLDERS EQUITY
Common stock525521521
Additional paid-in capital------
Retained earnings (accumulated deficit)(43)(105)(182)
Treasury stock - common(21)(19)(19)
Unrealized gain (loss)------
Other equity, total3.367.39--
Total equity464405320
Total liabilities & shareholders' equity1,007971800
Total common shares outstanding737373
Treasury shares - common primary issue0.240.100.10
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.